Plasma catestatin level predicts sPESI score and mortality in acute pulmonary embolism

INTRODUCTION: Acute pulmonary embolism (APE) is an emergent cardiothoracic disorder. The PESI score is used to estimate 30-day mortality in patients diagnosed with non-high-risk APE. Also, there are biomarkers for predicting prognosis and mortality in APE. Catestatin (CST) is accepted as a marker of...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Arch Med Sci Atheroscler Dis
Hlavní autoři: Izci, Servet, Acar, Emrah, Inanir, Mehmet
Médium: Artigo
Jazyk:Inglês
Vydáno: Termedia Publishing House 2020
Témata:
Clinical Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7277442/
https://ncbi.nlm.nih.gov/pubmed/32529106
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/amsad.2020.95562
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky